128 related articles for article (PubMed ID: 21592582)
1. Chronic Pneumocystis jiroveci presenting as asymptomatic granulomatous pulmonary nodules in lymphoma.
Kumar N; Bazari F; Rhodes A; Chua F; Tinwell B
J Infect; 2011 Jun; 62(6):484-6. PubMed ID: 21592582
[TBL] [Abstract][Full Text] [Related]
2. Single nodular opacity of granulomatous pneumocystis jirovecii pneumonia in an asymptomatic lymphoma patient.
Kim HS; Shin KE; Lee JH
Korean J Radiol; 2015; 16(2):440-3. PubMed ID: 25741206
[TBL] [Abstract][Full Text] [Related]
3. The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis.
Isidori A; Merli F; Angrilli F; Ferrara F; Alesiani F; Visani G
Leuk Lymphoma; 2011 Jan; 52(1):148-9. PubMed ID: 21067442
[No Abstract] [Full Text] [Related]
4. Exacerbation of lymphomatoid papulosis during rituximab therapy.
McCurdy O; McCormack C; Ritchie D; Prince HM
Australas J Dermatol; 2014 Feb; 55(1):e1-3. PubMed ID: 23190403
[TBL] [Abstract][Full Text] [Related]
5. Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.
Kurokawa T; Kaya H; Yoshida T
J Clin Exp Hematop; 2010; 50(2):159-62. PubMed ID: 21123974
[TBL] [Abstract][Full Text] [Related]
6. Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.
Venhuizen AC; Hustinx WN; van Houte AJ; Veth G; van der Griend R
Eur J Haematol; 2008 Mar; 80(3):275-6. PubMed ID: 18005387
[No Abstract] [Full Text] [Related]
7. Granulomatous Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma: case report and review of the literature.
Chang H; Shih LY; Wang CW; Chuang WY; Chen CC
Acta Haematol; 2010; 123(1):30-3. PubMed ID: 19940467
[TBL] [Abstract][Full Text] [Related]
8. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.
Hardak E; Oren I; Dann EJ; Yigla M; Faibish T; Rowe JM; Avivi I
Acta Haematol; 2012; 127(2):110-4. PubMed ID: 22178955
[TBL] [Abstract][Full Text] [Related]
9. Rituximab-induced serum sickness in a patient with follicular lymphoma.
Disperati P; Hicks LK; Buckstein R
Leuk Lymphoma; 2007 Aug; 48(8):1633-5. PubMed ID: 17701597
[No Abstract] [Full Text] [Related]
10. Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy.
Tsai MJ; Chou CW; Lin FC; Chang SC
Lupus; 2012 Jul; 21(8):914-8. PubMed ID: 22287506
[TBL] [Abstract][Full Text] [Related]
11. Granulomatous Reaction to Pneumocystis jirovecii Diagnosed in a Bronchoalveolar Lavage: A Case Report.
Nobile A; Valenti A; Aubert JD; Beigelman C; Letovanec I; Bongiovanni M
Acta Cytol; 2015; 59(3):284-8. PubMed ID: 26112359
[TBL] [Abstract][Full Text] [Related]
12. Apical Pneumocystis jiroveci as an AIDS defining illness: A case report illustrating a change in the paradigm.
Pfeifer K; Kalra V; Adebowale A; Juthani-Mehta M; Soo-Shin M
J Radiol Case Rep; 2014 Nov; 8(11):15-24. PubMed ID: 25926907
[TBL] [Abstract][Full Text] [Related]
13. [Follicular lymphoma showing long-term false positive results by FDG-PET after rituximab-containing chemotherapy].
Miyazaki Y; Nawa Y; Kohashi S; Nakase K; Miyagawa M; Hara M
Rinsho Ketsueki; 2012 Feb; 53(2):252-4. PubMed ID: 22450588
[TBL] [Abstract][Full Text] [Related]
14. Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome.
Sato M; Ito S; Ogura M; Kamei K; Miyairi I; Miyata I; Higuchi M; Matsuoka K
Pediatr Nephrol; 2013 Jan; 28(1):145-9. PubMed ID: 22948319
[TBL] [Abstract][Full Text] [Related]
15. [A case of follicular lymphoma with onset of chylothorax].
Hanaoka N; Nagao H; Murakami T; Chijiwa T; Suganuma T
Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):31-5. PubMed ID: 17313024
[TBL] [Abstract][Full Text] [Related]
16. [Economic analysis of rituximab in combination with cyclophosphamide, vincristine and prednisolone in the treatment of patients with advanced follicular lymphoma in Portugal].
Braga P; Carvalho S; Gomes M; Guerra L; Lúcio P; Marques H; Negreiro F; Pereira C; Silva C; Teixeira A
Acta Med Port; 2010; 23(6):1025-34. PubMed ID: 21627880
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
Carter SJ; Bernstein SH; Friedberg JW; Barr PM
Leuk Res; 2011 Nov; 35(11):e223-4. PubMed ID: 21824654
[No Abstract] [Full Text] [Related]
18. [Interstitial pneumonia connected with rituximab therapy--case report].
Wyrostkiewicz D; Skorupa W; Barańska I; Kuś J
Pneumonol Alergol Pol; 2013; 81(5):453-9. PubMed ID: 23996885
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis.
Hugle B; Solomon M; Harvey E; James A; Wadhwa A; Amin R; Bell-Peter A; Benseler S
Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1661-4. PubMed ID: 20583109
[TBL] [Abstract][Full Text] [Related]
20. Overview of Southwest Oncology Group Clinical Trials in non-Hodgkin Lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHL.
Fisher RI
Clin Adv Hematol Oncol; 2005 Jul; 3(7):544-6. PubMed ID: 16167036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
